PortfoliosLab logo

Aquestive Therapeutics, Inc. (AQST)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS03843E1047
CUSIP03843E104
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.93
Year Range$0.63 - $6.22
EMA (50)$1.01
EMA (200)$1.88
Average Volume$655.30K
Market Capitalization$48.25M

AQSTShare Price Chart


Loading data...

AQSTPerformance

The chart shows the growth of $10,000 invested in Aquestive Therapeutics, Inc. in Jul 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $573 for a total return of roughly -94.27%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%JuneJulyAugustSeptemberOctoberNovember
-7.43%
-2.57%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

AQSTCompare to other instruments

Search for stocks, ETFs, and funds to compare with AQST

AQSTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.77%4.33%
6M-6.12%-0.78%
YTD-76.35%-15.53%
1Y-85.26%-14.36%
5Y-48.27%8.33%
10Y-48.27%8.33%

AQSTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-30.08%2.57%-6.45%-46.36%-29.00%-35.61%28.44%75.79%-19.03%-25.64%5.75%
2021-1.12%-13.42%13.54%-21.73%-8.85%7.01%-18.14%40.92%-4.80%17.89%14.79%-34.07%
2020-30.41%-7.90%-41.29%96.80%12.99%-0.21%8.23%49.43%-38.23%-0.31%45.87%-24.22%
2019-2.70%31.32%-14.16%-17.37%-34.85%12.90%-18.81%11.44%-16.32%20.75%102.86%-25.29%
2018-6.29%19.75%-2.78%-13.59%-43.23%-26.66%

AQSTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aquestive Therapeutics, Inc. Sharpe ratio is -0.89. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JuneJulyAugustSeptemberOctoberNovember
-0.89
-0.60
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

AQSTDividend History


Aquestive Therapeutics, Inc. doesn't pay dividends

AQSTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-95.15%
-16.06%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)

AQSTWorst Drawdowns

The table below shows the maximum drawdowns of the Aquestive Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aquestive Therapeutics, Inc. is 96.68%, recorded on Jul 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.68%Sep 10, 2018960Jul 1, 2022
-6.54%Jul 26, 20188Aug 6, 20185Aug 13, 201813
-6.17%Aug 15, 20189Aug 27, 20182Aug 29, 201811
-0.67%Sep 4, 20181Sep 4, 20182Sep 6, 20183

AQSTVolatility Chart

Current Aquestive Therapeutics, Inc. volatility is 56.80%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%JuneJulyAugustSeptemberOctoberNovember
56.80%
12.31%
AQST (Aquestive Therapeutics, Inc.)
Benchmark (^GSPC)